Vertebrate oocytes await fertilization arrested at metaphase of the second meiotic division. Fertilization triggers a transient calcium wave, which induces the activation of the anaphasepromoting complex/cyclosome (APC/C) and its co-activator Cdc20 resulting in the destruction of cyclin B and hence meiotic exit. Two calcium-dependent enzymes are implicated in fertilizationinduced APC/C Cdc20 activation: calcium-/calmodulin-dependent kinase type II (CaMKII) and calcineurin (CaN). While the role of CaMKII in targeting the APC/C inhibitor XErp1/Emi2 for destruction is well-established, it remained elusive how CaN affects APC/C Cdc20 activation. Here, we discover that CaN contributes to APC/C Cdc20 activation in Xenopus laevis oocytes by two independent but interrelated mechanisms. First, it facilitates the degradation of XErp1 by dephosphorylating it at a site that is part of a phosphorylationdependent recruiting motif for PP2A-B 0 56, which antagonizes inhibitory phosphorylation of XErp1. Second, it dephosphorylates Cdc20 at an inhibitory site, thereby supporting its APC/Cactivating function. Thus, our comprehensive analysis reveals that CaN contributes to timely APC/C activation at fertilization by both negatively regulating the APC/C inhibitory activity of XErp1 and positively regulating the APC/C-activating function of Cdc20.
Introduction
In vertebrates, fertilizable oocytes are arrested at metaphase of the second meiotic division (MII) in a state with active Cdk1/cyclin B and inactive APC/C Cdc20 [1, 2] . This MII arrest is mediated by a biochemical activity termed cytostatic factor (CSF) composed of the APC/C inhibitor XErp1/Emi2 and factors mediating its activation [3] [4] [5] [6] . XErp1/Emi2 binds directly to the APC/C and inhibits it by multiple mechanisms [7] [8] [9] . In Xenopus oocytes, activation of XErp1 requires its phosphorylation by the 90-kDa ribosomal protein S6 kinase (p90 RSK ), the downstream kinase of the c-Mos-/mitogen-activated protein kinase (MAPK) pathway [5, 6] . Upon phosphorylation of XErp1 by p90 RSK , protein phosphatase PP2A in complex with the regulatory B 0 56 subunit binds to XErp1 and protects it from inhibitory phosphorylation by Cdk1/cyclin B and other kinases [10, 11] . In Xenopus oocytes, the transient rise in calcium levels associated with fertilization causes the activation of the kinase CaMKII and the phosphatase calcineurin (CaN, also called PP2B) [12] [13] [14] . The role of CaMKII in meiotic exit is well-established and seems to be highly conserved across species [15] . Activated CaMKII phosphorylates XErp1 at Thr195 and thereby creates a docking site for polo-like kinase 1 (Plx1) [16] . Plx1 recruited to XErp1 phosphorylates it at a site that serves as a phosphodegron for the ubiquitin ligase SCF (Skp, Cullin, F-box) in complex with the F-Box protein bTRCP (beta-transducin repeat containing protein) resulting ultimately in the destruction of XErp1 and hence APC/C Cdc20 activation [4] . In contrast, the role of CaN during meiotic exit remains largely elusive. Data from porcine and mouse oocytes suggested that CaN activity is required for timely exit from MII, but the relevant substrates are not known [15, 17] . In Xenopus oocytes, CaN is also required for proper release from the MII arrest. Yet, the underlying molecular mechanisms remained elusive. One study reported that CaN inhibition interferes with the SCF bTRCP -mediated destruction of XErp1 resulting in impaired APC/C Cdc20 activation [14] . Another study came to the conclusion that CaN does not act on XErp1, but that it promotes APC/C activation by removing inhibitory phosphorylations on Cdc20 [13] . However, it remained elusive whether CaN directly or indirectly mediates the dephosphorylation of any of the known three inhibitory phosphorylation sites Thr64, Thr68, and Thr79 (human/ mouse: Thr55, Thr59, and Thr70) of Cdc20 [18] [19] [20] [21] . In somatic cells, PP2A was shown to activate Cdc20 by dephosphorylating it at these inhibitory sites [19, 22] .
Here, we aimed to dissect in detail the role of CaN during meiotic exit. For these studies, we employed the well-established cell-free extract system of Xenopus oocytes [23, 24] . We discover that CaN promotes APC/C Cdc20 activation by acting on both the APC/C inhibitor XErp1 and the APC/C co-activator Cdc20. Specifically, we demonstrate that CaN inhibition interfered with timely destruction of XErp1. Using a non-degradable XErp1 version, we could demonstrate that CaN inhibition unexpectedly accelerated the dephosphorylation of XErp1 during meiotic exit. We could demonstrate that CaN dephosphorylates XErp1 at a site that is part of a phosphorylation-dependent recruiting motif for PP2-B'56, which protects XErp1 from inactivating and destabilizing phosphorylation events [5, 6, 10, 11] . In the case of Cdc20, CaN inhibition delayed the calcium-induced dephosphorylation. CaN directly dephosphorylates Cdc20 at Thr68, which when phosphorylated impairs Cdc20 from activating the APC/C [20, 22] . Thus, the calcium stimulus at fertilization branches into the activation of CaMKII and CaN, which join efforts to activate the APC/C in a highly efficient manner.
Results and Discussion
To investigate the role of calcineurin during exit from meiosis II, we prepared extracts from mature eggs (CSF extracts) of Xenopus laevis ( Fig 1A) [23, 24] and monitored cyclin B2 levels following calciuminduced release from the MII arrest. In control-treated extracts (DMSO for CsA; buffer for His-CnA 420-508 ), cyclin B2 levels markedly declined within 8 min after calcium addition (Figs 1B and EV1A). Inhibition of CaN by CsA or the auto-inhibitory domain of the catalytic subunit CnA [14] fused to a His-tag (His-CnA 420-508 ) slightly delayed the degradation of cyclin B2 ( Fig 1B) . Thus, our data confirmed that CaN inhibition results in a mild but reproducible delay in APC/C activation at exit from MII [13, 14] .
Depletion of XErp1 from CSF extract or addition of constitutively active CaMKII is sufficient to activate the APC/C in the absence of the calcium stimulus, indicating that the CaMKII-mediated destruction of XErp1 constitutes the major APC/C-activating pathway [4, 12] . Notably, CaMKII-like CaN-is activated only very transiently during calcium-induced meiotic exit [12, 14] . We therefore speculated that CaN constitutes an auxiliary pathway that supports CaMKII to reduce-within the narrow time window when they are active-the APC/C inhibitory activity of XErp1 to levels sufficiently low to allow exit from meiosis. A corollary of this hypothesis is that conditions that hamper CaMKII-mediated XErp1 inactivation should increase the contribution of CaN to meiotic exit. To test this, we first challenged the release from MII by titrating the amount of calcium added to CSF extracts. As expected, upon a strong calcium stimulus (≥ 500 lM) we observed the complete degradation of cyclin B2 within 20 min in DMSO-as well as in CsA-treated extracts ( Fig 1C) . Importantly, at intermediate calcium concentrations (300 and 400 lM), cyclin B2 degradation was markedly impaired in CaN-inhibited extracts. Lower calcium concentrations (200 lM) failed to sufficiently activate the APC/C, even in the presence of CaN activity. Similar results were obtained when the experiment was repeated using FK506 to inhibit CaN ( Fig EV1B) . Second, we challenged exit from MII by adding increasing amounts of the CaMKII inhibitory peptide CaMKII 281-309 . While high concentrations (300 lg/ml) completely blocked calcium-induced cyclin B2 degradation irrespective of CaN activity, at intermediate concentrations (100 lg/ml), efficient cyclin B2 degradation occurred only in DMSO-but not CsA-treated extracts ( Fig EV1C) . Third, we aggravated meiotic exit by adding increasing amounts of ectopic in vitrotranslated (IVT) Myc-tagged wild-type XErp1 (Myc-XErp1 wt ) to CSF extracts. Since XErp1 undergoes phosphorylation-dependent mobility shifts in SDS-PAGE, samples were treated with k-phosphatase before immunoblot analyses. As expected, in the absence of ectopic XErp1 and at high calcium concentrations, CaN inhibition had only a mild effect on cyclin B2 destruction ( Fig 1D, lane 1-3 vs. 4-6). However, when the amount of XErp1 in the extract was roughly doubled (1:160 IVT Myc-XErp1 wt ), cyclin B2 degradation was significantly inhibited in CsA-treated extracts compared to the DMSO control (lane 7-9 vs. [10] [11] [12] . Further increases in XErp1 wt interfered with cyclin B2 degradation in control-as well as in CsA-treated extracts (lanes [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . The effect of ectopic XErp1 on cyclin B2 degradation was dependent on XErp1's APC/C inhibitory activity as XErp1 deficient in APC/C inhibition had no effect ( Fig EV1D) . Notably, we observed that endogenous as well as ectopic XErp1 was less efficiently degraded in CsA-treated extracts ( Fig 1D) . To confirm this, we repeated the assay with increased temporal resolution. CaN inhibition had no significant effect on the initial degradation of endogenous and exogenous XErp1 ( Figs 1E and EV1E ). However, while in control extracts the destruction of endogenous and exogenous XErp1 continued, it ceased in CsA-treated extracts. As expected, the decline in XErp1 destruction in CsA-treated extracts coincided with a decreased rate of cyclin B2 degradation (Figs 1E and EV1E). Thus, in line with previous reports [14] these data suggest that CaN contributes to meiotic exit by promoting the destruction of XErp1.
Next, we sought to gain more insight into the mechanism of CaN-mediated XErp1 destruction. At fertilization, the coordinated activities of CaMKII and Plx1 target XErp1 for SCF ßTRCP -mediated degradation [4, 10, 16] . Based on this, we investigated whether CaN affects the phosphorylation state of XErp1 following fertilization. To uncouple the phosphorylation of XErp1 from its destruction, we supplemented CSF extract with Myc-XErp1 that carried mutations in the SCF bTRCP phospho-degrons (DSG À DSA À , Fig 2A) [4, 6] . Furthermore, to prevent that stable Myc-XErp1 DSGÀDSAÀ interfered with APC/C activation we introduced an additional mutation in its zincbinding region (ZBR À ), which abrogates XErp1 0 s APC/C inhibitory activity [4, 9] . Addition of calcium induced an immediate hyperphosphorylation of Myc-XErp1 DSGÀDSAÀZBRÀ that was not affected by inhibition of CaN with CsA ( Fig 2B) . However, after around 10 min the hyperphosphorylation of ectopic XErp1 was gradually reversed in CsA-treated extracts (see arrow in Fig 2B and in the pseudocolored image in Fig EV2A) and this was less pronounced in controltreated extracts. Importantly, the same effect was observed when CaN was inhibited by FK506 ( Fig EV2B) . Notably, the effect of CaN inhibition on the dephosphorylation of XErp1 DSGÀDSAÀZBRÀ ( Fig 2B) temporally correlated with its effect on the destruction of XErp1 wt (Fig 1E) , suggesting that CaN might control phosphorylation events involved in XErp1 destruction. As expected, under these conditions (600 lM calcium, ectopic XErp1 deficient in APC/C inhibition) CaN inhibition only mildly affected cyclin B2 destruction. From these data, we conclude that CaN activity is required to, counterintuitively, maintain XErp1 in a hyperphosphorylated state during meiotic exit. One explanation for this unexpected finding could be that CaN negatively regulates the activity of another phosphatase acting on XErp1. The only known XErp1 phosphatase is PP2A-B'56, which is recruited to XErp1 by a canonical B 0 56 binding motif [10, 11, 25] . Phosphorylation of XErp1 on Ser335, Thr336, and Ser342 by p90 RSK significantly increases its affinity for PP2A-B 0 56 [5, 6, 10, 11, 25] . If CaN interferes with the dephosphorylation of XErp1 by PP2A-B'56, preventing the recruitment of PP2A-B'56 to XErp1 should abolish the effect of CaN inhibition. To test this, we mutated all three p90 RSK phosphorylation sites to alanine residues (Myc-XErp1 DSGÀDSAÀZBRÀRsk3A ) and analyzed its dephosphorylation upon meiotic exit. As shown before ( Fig 2B) , Myc-XErp1 DSGÀDSAÀZBRÀ was initially hyperphosphorylated after calcium addition and the subsequent dephosphorylation was accelerated by CsA ( Fig 2C, A Scheme for the preparation of CSF extract. B CSF extract was treated with DMSO, CsA, buffer or His-CnA 420-508 at the indicated concentrations. Meiotic exit was induced by calcium addition, and samples were taken at the indicated time points. Samples were immunoblotted for cyclin B2. The cyclin B2 membrane was stripped and reprobed for a-tubulin. C CSF extract was treated with DMSO or CsA. Both reactions were divided and supplemented with the indicated amounts of calcium or H 2 O. After 20 min, samples were taken and immunoblotted for cyclin B2 for which a low and high exposure is shown. The cyclin B2 membrane was stripped and reprobed for a-tubulin. D CSF extract was supplemented with Myc-XErp1 wt IVT at the indicated dilutions. An empty IVT reaction not expressing Myc-XErp1 served as control. All reactions were divided and treated with DMSO or CsA. Calcium was added to all reactions, and samples were taken at the indicated time points, treated with k-phosphatase and immunoblotted for XErp1, the Myc-tag, cyclin B2, and a-tubulin. Asterisks indicate unspecific bands. E CSF extract was supplemented with Myc-XErp1 wt IVT. The reaction was divided and treated with DMSO or CsA. Both reactions were treated with calcium, and samples were taken at the indicated time points and as indicated incubated with k-phosphatase. Samples were immunoblotted for XErp1 and cyclin B2. The cyclin B2 membrane was stripped and reprobed for a-tubulin. Asterisk indicates unspecific bands.
Source data are available online for this figure. A Schematic representation of the XErp1 variants and their characteristics used in this study. B CSF extract was supplemented with Myc-XErp1 DSG À DSA À ZBR À (S33N S38N S284N S288N C583A) IVT and as indicated treated with DMSO or CsA. Both reactions were treated with calcium and samples were taken at the indicated time points. Samples were immunoblotted for the Myc-tag, cyclin B2, and a-tubulin. A pseudocolored representation of the Myc immunoblot is shown in Fig EV2A. Arrow marks the meiotic phosphorylation state of Myc-XErp1. Asterisk indicates unspecific bands. C CSF extract was supplemented with Myc-XErp1 DSG À DSA À ZBR À (S33N S38N S284N S288N C583A) IVT that was either wild-type or mutated to alanine at the p90 RSK -target sites S335, T336, and S342 (Rsk 3A ). Both reactions were divided and treated with DMSO or CsA. Calcium was added, and samples were taken at the indicated time points. Samples were immunoblotted for the Myc-tag and cyclin B2. The cyclin B2 membrane was stripped and reprobed for a-tubulin. Asterisk indicates unspecific bands. D CSF extract was treated with Myc-XErp1 CaMKII À ZBR À (T195A C583A) IVT. An empty IVT reaction not expressing XErp1 was used as control. The extracts were treated with DMSO or CsA as indicated. Calcium was added, and samples were taken at the indicated time points and immunoblotted for cyclin B2, pSer335 XErp1, and a-tubulin. The pSer335 XErp1 membrane was stripped and reprobed for the Myc-tag. Asterisks indicate unspecific bands. E Myc-XErp1 CaMKII À ZBR À (T195A C583A) IVT was in vitro phosphorylated by recombinant PKA and isolated by a-Myc immunoprecipitation. The immunoprecipitate was supplemented with calcium and treated with recombinant hs_CaN and calmodulin as indicated. Samples were taken at the indicated time points and immunoblotted for the catalytic calcineurin subunit CnA and pSer335 XErp1. The pSer335 XErp1 membrane was stripped and reprobed for the Myc-tag. Asterisk indicates the IgG heavy chain.
Source data are available online for this figure.
in CSF extract (lane 1/7 vs. 13/19), suggesting in line with previous reports [10, 11] that PP2A-B'56 antagonizes phosphorylation of XErp1 by Cdk1 and other kinases during the MII arrest. Importantly, the dephosphorylation of Myc-XErp1 DSGÀDSAÀZBRÀRsk3A following calcium treatment was not significantly different in control-treated extracts compared to the CsA samples (lanes 13-18 vs. [19] [20] [21] [22] [23] [24] supporting our hypothesis that CaN negatively affects the PP2A-B'56-mediated dephosphorylation of XErp1. To further corroborate this hypothesis, we performed the reverse experiment in that we mutagenized the p90 RSK -dependent PP2A-B'56 binding site in XErp1 [25] to a phosphorylation-independent binding motif (LSTLRERGSQS 344 ? LPTIREEEEQS 344 , XErp1 B56+ ). Co-IP experiments confirmed that these mutations resulted in stronger PP2A-B'56 binding ( Fig EV2C) . Importantly, the phosphorylation state of Myc-XErp1 DSGÀDSAÀZBRÀB56+ upon calcium stimulation was not affected by CaN inhibition, suggesting that the regulation of XErp1 by CaN was bypassed under these conditions ( Fig EV2D) . The most direct explanation for this would be that CaN dephosphorylates the p90 RSK -target sites. To test this, we raised a phosphorylation-specific antibody against Ser335 (pSer335). Due to low sensitivity of the antibody, we had to supplement extracts with IVT XErp1. To prevent the calcium-induced upshift, which would hamper the analyses of pSer335, we used XErp1 with a mutation in the CaMKII phosphorylation site (Fig EV3A, Thr195? A, CaMKII À ). Adding Myc-XErp1 CaMKIIÀZBRÀ to CSF extract resulted in a pSer335 signal whose strength correlated with the amount of added protein ( Fig EV3B) . This signal was specific for pSer335 because it was lost upon k-phosphatase treatment or mutation of Ser335 to alanine ( Fig EV3C) . After having validated the antibody, we analyzed the phosphorylation state of Ser335 during meiotic exit. Indeed, the pSer335 signal decreased upon calcium-induced MII release ( Fig 2D) . The pSer335 signal did not disappear completely in the DMSO control probably because the amount of added IVT XErp1 exceeded the capacity of the phosphatases acting on XErp1. Importantly, in CsA-treated extract the pSer335 signal did not significantly decline upon calcium stimulation, indicating that CaN directly or indirectly mediates the dephosphorylation of Ser335 during meiotic exit. To test whether CaN directly dephosphorylates pSer335, we established an in vitro phosphatase assay. Specifically, Myc-XErp1 CaMKIIÀZBRÀ was incubated with recombinant protein kinase A (PKA), which phosphorylates XErp1 at Ser335 during early embryonic divisions [26] . Pre-phosphorylated XErp1 was subsequently incubated with recombinant human CaN (hs_CaN), which shows high sequence conservation with Xenopus CaN, in the presence of calcium with or without calmodulin [27, 28] . In the absence of CaN, the pSer335 signal remained constant throughout the time course (Fig 2E) . In the presence of calmodulin, incubation of pre-phosphorylated XErp1 with hs_CaN resulted in a dose-dependent decrease in the pSer335 signal.
In the absence of calmodulin, pSer335 was weakly dephosphorylated by CaN confirming previous reports [29] that CaN even in the absence of its co-activator has some basal activity. Studies on mammalian Emi2 have suggested that phosphorylation of Ser385 (Ser335 in XErp1) increases the affinity for B 0 56 roughly 2,6-fold [25] . We therefore speculated that CaN contributes to the inactivation and destabilization of XErp1 due to a weakened association of the protective phosphatase PP2A-B 0 56 [10, 11] . To test this, we analyzed whether CaN inhibition affects the association of XErp1 with PP2A-B'56 during meiotic exit. Unfortunately, co-IP experiments using ectopic XErp1 and PP2A-B'56 did not yield conclusive results. Irrespective of this, these experiments indicate that CaN contributes to XErp1 destabilization at fertilization by dephosphorylating it directly at Ser335. Next, we analyzed the function of CaN in the dephosphorylation of Cdc20 at meiotic exit. During CSF arrest, Cdc20 is phosphorylated by Cdk1 at three threonine residues (Thr64, Thr68, and Thr79) and these phosphorylation events prevent Cdc20 from activating the APC/C [18, 20, 22] . In contrast, the APC/C has to be phosphorylated by Cdk1 on multiple serine residues to be active [30] [31] [32] . The paradox of how such a regulation allows the formation of active APC/C Cdc20 was recently solved by demonstrating that PP2A-B55, the phosphatase acting on Cdc20 and APC/C in mitosis, has a strong preference for pThr resulting in temporally ordered dephosphorylation events with Cdc20 being dephosphorylated before the APC/C [19] . To test whether the same mechanism applies in meiosis, we analyzed the dephosphorylation kinetics of ectopic wild-type and mutant Cdc20 with the three inhibitory threonine sites mutated to serine (3T?S) during meiotic exit. Using Phos-tag TM SDS-PAGE [33] , which enhances the mobility shift of phosphorylated proteins, we observed that Flag-Cdc20 wt was quickly dephosphorylated with the first signs of dephosphorylation being detectable at 5 min after calcium addition ( Fig 3A) . Faster migrating forms of the APC/C subunit Cdc27 were not detectable until 20 min in line with the idea that differential dephosphorylation kinetics allow the formation of active APC/C Cdc20 [19] . Importantly, the 3T?S mutation abolished the time lag between Cdc20 and APC/C dephosphorylation. Please note that this did not affect cyclin B2 destruction due to the presence of endogenous Cdc20. From these data, we conclude that a calcium-activated phosphatase with a pThr preference acts on Cdc20. Given the reported preference of CaN for pThr and the effect of its inhibition on APC/C Cdc20 activation [13, 34] , we analyzed next in detail the effect of CaN inhibition on the phosphorylation state of Cdc20. In Phos-tag TM SDS-PAGE, endogenous Cdc20 showed a strong phosphorylation-dependent mobility shift in CSF extract, which was quickly reverted upon calcium addition ( Fig 3B) . We observed also late dephosphorylation events (16-24 min) occurring after the reported activity window of CaN [13, 14] . Non-Phos-tag TM SDS-PAGE confirmed that Cdc20 levels remained constant during the experiment. Importantly, CaN inhibition by CsA or FK506 strongly inhibited the early but not late dephosphorylation of Cdc20 ( Figs 3B and EV4A and B) . Thus, in line with previous reports [13] , we conclude from these data that CaN-directly or indirectly-mediates the initial dephosphorylation of Cdc20, while other phosphatase(s) act later on it. Next, we analyzed whether CaN targets the inhibitory sites of Cdc20. Given that all three inhibitory sites seem to be equally important for Cdc20 regulation [20] , we focused on Thr68 for which suitable phospho-specific antibodies were available. After immunoprecipitating IVT Flag-Cdc20 from CSF extract, the pThr68 antibody detected a signal that was absent when the samples were treated with kphosphatase or when Thr68 was mutated to alanine ( Fig EV4C) indicating that Cdc20 is phosphorylated at Thr68 in MII. Adding calcium resulted in a fast dephosphorylation of Thr68, and importantly, this was strongly impaired in CsA-treated extracts (Fig 3C) . Next, we analyzed whether CaN directly dephosphorylates Thr68. Specifically, we incubated Flag-Cdc20 in CSF extract, re-isolated it, and incubated pre-phosphorylated Flag-Cdc20 with recombinant hs_CaN. As in the case of Ser335 of XErp1, we observed that Thr68 of Cdc20 was efficiently dephosphorylated by CaN in the presence of its co-activator calmodulin, but not in its absence (Fig 3D) . From these data, we conclude that Cdc20 is phosphorylated at Thr68 during metaphase II and that CaN directly dephosphorylates Cdc20 at this inhibitory site during meiotic exit.
In summary, based on our comprehensive analyses we propose the following model of CaN function during exit from meiosis ( Fig 4A) . During the MII arrest of Xenopus oocytes, the activity of the APC/C is kept low by the presence of its inhibitor XErp1 and by inhibitory phosphorylation of its co-activator Cdc20 [4, 18, 20] . Fertilization triggers a transient calcium wave in the oocyte, and this signal branches in the activation of CaMKII and CaN [12] [13] [14] 35] . CaMKII acts as a priming kinase for Plx1, which in turn creates a phosphorylation-dependent recognition motif (DpSGxxxpS 38 ) in XErp1 for the E3 ligase SCF ßTRCP [4, 16] . In parallel, CaN dephosphorylates XErp1 at Ser335 and this dephosphorylation event impedes PP2A-B'56 from protecting XErp1 against inhibitory phosphorylations (Fig 2) . Thus, CaN supports CaMKII in targeting XErp1 for destruction and the concerted effort of both enzymes ensures that A CSF extract was supplemented with mRNA encoding Flag-Cdc20 that was either wild-type or mutated to serine at Thr64, Thr68, and Thr79 (3T?S). After expression, calcium was added, samples were taken at the indicated time points and resolved by either conventional or Phos-tag TM SDS-PAGE. Samples were immunoblotted for the Flag-tag, Cdc27, and cyclin B2. B CSF extract was supplemented with Myc-XErp1 wt IVT and treated with DMSO or CsA. Calcium was added, samples were taken at the indicated time points, resolved by either conventional or Phos-tag TM SDS-PAGE and immunoblotted for Cdc20, Cdc27, and cyclin B2. A control sample was treated with k-phosphatase. A pseudocolored representation of the Cdc20 and the Cdc27 immunoblots is shown in Fig EV4A. The cyclin B2 membrane was stripped and reprobed for a-tubulin. C CSF extract was supplemented with Flag-Cdc20 wt IVT coupled to a-Flag beads. Calcium was added, and Flag-Cdc20 was isolated by a-Flag immunoprecipitation at the indicated time points. Input and pellet (IP: Flag) samples were immunoblotted for the Flag-tag, pThr68 Cdc20 and p150(Glued). The pThr68 Cdc20 membrane was stripped and reprobed for cyclin B2. Asterisk in the cyclin B2 immunoblot indicates the IgG heavy chain. Asterisks in other immunoblots indicate unspecific bands. D CSF extract was supplemented with Flag-Cdc20 wt IVT. Flag-Cdc20 was re-isolated by a-Flag immunoprecipitation, supplemented with calcium and treated with recombinant hs_CaN and calmodulin as indicated. Samples were taken at the indicated time points and immunoblotted for the Flag-tag and pThr68 Cdc20. The pThr68 Cdc20 membrane was stripped and reprobed for the catalytic calcineurin subunit CnA. Asterisk indicates the IgG heavy chain.
XErp1 levels drop fast enough within the narrow time window of CaMKII and CaN activity. In parallel, CaN contributes to APC/C activation by dephosphorylating its co-activator Cdc20 at the inhibitory site Thr68 (and possibly also at Thr64 and Thr79, Fig 3) . Active APC/C Cdc20 liberated from its inhibitor XErp1 subsequently targets cyclin B and securin for degradation resulting in sister chromatid segregation and meiotic exit. So far, we could not identify known binding motifs of CaN on XErp1 and Cdc20, e.g., "PxIxIT" or "LxVP" motifs [36] [37] [38] . Thus, future studies will be important to decipher the exact binding mode of CaN to Cdc20 and XErp1. Reportedly, CaN activates at meiotic exit the translation regulator maskin, which then suppresses cyclin B translation [39] . This reduction in cyclin B synthesis might synergize with increased APC/C activation to ensure low cyclin B levels at the transition to interphase of the first embryonic division.
Materials and Methods

CSF extracts
Xenopus laevis frogs were bred and maintained under laboratory conditions at the animal research facility, University of Konstanz, and all procedures performed were approved by the Regional Commission, Freiburg, Germany. Female Xenopus laevis frogs were primed 3-7 days before extract preparation by subcutaneous injection of 50 units PMSG (Intervet). On the evening before extract preparation, the frogs were subcutaneously injected with 800 units hCG (Intervet) to induce ovulation. The frogs were kept in 1× MMR buffer (5 mM HEPES; 0.1 mM EDTA; 100 mM NaCl; 2 mM KCl; 1 mM MgCl 2 ; 2 mM CaCl 2 ; pH = 7.8) at 19°C overnight. On the following morning, the mature eggs were collected and washed in 1xMMR if necessary. . The oocytes were transferred to centrifugation tubes containing 750 ll 1× CSF-XB supplemented with 100 lg/ml cytochalasin B (Cayman Chemical). The oocytes were compacted for 1 min with 164 g at 4°C and for 1 min with 656 g at 4°C. Excess supernatant was removed, and the oocytes were crushed by centrifugation for 10 min with 16,398 g at 4°C. The CSF extract was retrieved with a syringe and supplemented with 10 lg/ml cytochalasin B (Cayman Chemical). The extract was kept on ice until used in experiments. Unless otherwise stated, all experiments were performed at 20°C. CaN inhibitors were added for 5 min before meiotic exit was induced. Cyclosporin A (Calbiochem) and FK-506 (Sigma-Aldrich) were dissolved in DMSO and added at a final concentration of 2 lM and 3 lM, respectively. His-CnA 420-508 was dissolved in dialysis buffer and added at 20 ng/ll. CaM Kinase II Inhibitor 281-309 (CaMKII 281-309 , Calbiochem) was dissolved in 1× CSF-XB and added at the indicated concentrations. All in vitro transcription and translation reactions (IVTs) were incubated in CSF extract for at least 20 min prior further treatments. IVTs without a protein-coding plasmid (empty) were used as control.
Recombinant proteins and mRNAs
His-CnA 420-508 (Xenopus laevis, 6xHis-tag, aa420-508) was expressed in BL21(RIL) bacteria, purified by Ni 2+ -NTA agarose affinity chromatography and dialyzed against dialysis buffer (20 mM HEPES; 150 mM KCl; 1 mM DTT; 10% (v/v) glycerol; pH = 7.7). Calmodulin was purchased from Sigma-Aldrich. Recombinant human calcineurin dimer (hs_CaN) was purchased from R&D systems. Recombinant PKA was purchased from Calbiochem. All other proteins were expressed as IVTs in TNT â SP6 High-Yield Wheat Germ Protein Expression System (Promega) according to the manufacturer 0 s instructions: Myc-XErp1 wt (Xenopus laevis, 6xMyctag, wild-type); Myc-XErp1 ZBR À (Xenopus laevis, 6xMyc-tag, C583A); Myc-XErp1 DSG À DSA À ZBR À (Xenopus laevis, 6xMyc-tag, S33N S38N S284N S288N C583A); Myc-XErp1 DSG À DSA À ZBR À Rsk 3A (Xenopus laevis, 6xMyc-tag, S33N S38N S284N S288N S335A T336A S342A C583A); Myc-XErp1 DSG À DSA À ZBR À B56 + (Xenopus laevis, 6xMyc-tag, S33N S38N S284N S288N S335P L337I R340E G341E S342E C583A); Myc-XErp1 CaMKII À ZBR À (Xenopus laevis, 6xMyc-tag, T195A C583A); Myc-XErp1 CaMKII À ZBR À S335A (Xenopus laevis, 6xMyc-tag, T195A S335A C583A); Flag-Cdc20 wt (Xenopus laevis, 3xFlag-tag, wild-type); Flag-Cdc20 T68A (Xenopus laevis, 3xFlag-tag, T68A); Flag-Cdc20 3T?S (Xenopus laevis, 3xFlag-tag, T64S T68S T79S). mRNA for Flag-B 0 56e (Xenopus laevis, 3x-Flagtag, wild-type) was prepared using the mMESSAGE mMACHINE TM T7 Ultra Transcription Kit (Invitrogen) according to the manufacturer 0 s instructions. Further details will be provided upon request.
Immunoblots
Where indicated, 15 lM Phos-tag TM (Wako Pure Chemical Industries) and 30 lM MnCl 2 were added to standard SDS-PA gels. Proteins were transferred to nitrocellulose membranes (Whatman Protran). Membranes were blocked in 5%(w/v) milk/PBST for 30 min. Membranes that were probed with phospho-antibodies were blocked with 5%(w/v) BSA/TBST. Primary antibodies were diluted in 5%(w/v) milk/PBST and primary phospho-antibodies in 5%(w/v) BSA/TBST. All primary antibodies were added to the membranes at 4°C overnight. Membranes were washed three times with PBST or TBST for 10 min. Secondary antibodies (HRPcoupled, a-mouse and a-rabbit, Dianova) were diluted 1:5,000 in the solution used for blocking and incubated at room temperature for 1 h. Membranes were washed again three times with PBST or TBST for 10 min. The membranes were covered with ECL solution (TrisCl pH 8.5; 0,012% H 2 O 2 ; 225 lM P-coumaric acid (Sigma-Aldrich); 1.25 mM luminol (Fluka)). Chemiluminescent signals were detected with a LAS-3000 (GE Healthcare Life Sciences).
Immunoblot analysis
Band intensities in immunoblots were quantified using ImageJ. Calculations were done using Microsoft Excel 2013. Bar graphs were generated using GraphPad Prism 6. Pseudocolor representations of immunoblots were made using Fujifilm Multi Gauge V3.0.
Antibodies
XErp1 (diluted 1:1,000) and Cdc27 (1:500) antibodies were described before [26] . Cyclin B2 antibody (1:500) was purchased from Santa Cruz (sc-53239). Calcineurin A antibody (1:500) was purchased from BD Transduction Laboratories (No. 610260). Cdc20 antibody (1:500) was purchased from Abcam (ab18217). p150 (Glued) antibody (1:1,000) was purchased from BD Transduction Laboratories (No. 610473). Flag-tag antibodies (for immunoprecipitation and immunoblot) were diluted 1:1,000 and purchased from Sigma-Aldrich (F1804) or generated by immunization of rabbits with Flag-peptide (NH2-CMDYKDHDGDYKDHDIDYKDDDDK-COOH) and purification against the Flag-peptide. Phospho-Ser335 XErp1 antibody (1:1,000) was generated by immunization of rabbits with pS335 peptide (NH2-CRRLpSTLRER-COOH) and positive purification against the pS335 peptide followed by negative purification against S335 peptide (NH2-CRRLSTLRER-COOH). Myc-tag antibody for immunoprecipitation and immunoblot (1:100) was purified from hybridoma cells (9E10). a-Tubulin antibody (1:100) was purified from hybridoma cells (DSHB 12G10). Phospho-Thr68 Cdc20 antibody was a gift from J. Nilsson.
k-phosphatase treatment
Extract samples were dephosphorylated by dilution in five volumes of k-phosphatase Mix (137 mM NaCl; 2.7 mM KCl; 10 mM Na 2 HPO 4 ; 2 mM KH 2 PO 4 ; 1 mM MnCl 2 ; 1× Protease Inhibitor Complete (Roche); 0.2 lg/ll 6xHis-SUMO-k-PPtase; pH = 7.4) and incubation for 45 min at 23°C. Bead samples were resuspended in k-phosphatase Mix and incubated for 45 min at 23°C.
Analysis of phospho-Thr68 Cdc20
15.2 ll CSF extract was supplemented with 0.8 ll Flag-Cdc20 IVT. The mixture was added to 1 lg a-Flag antibodies coupled to Dynabeads â Protein G (Thermo Fisher). The reaction was incubated for 60 min. 50 ll Wash Buffer (20 mM HEPES; 100 mM KCl; 5 mM MgCl 2 ; 0.025% Tween-20; 5 mM b-glycerophosphate; 2 mM NaF; pH = 7.5) was added, and the whole supernatant was removed. The beads were washed three times with Wash Buffer. The beads were directly resuspended in 30 ll 1.5× Laemmli Sample Buffer or treated with k-phosphatase.
In vitro phosphatase assays XErp1: 2 ll Myc-XErp1 IVT were diluted in 8 ll CSF-XB Buffer (10 mM HEPES; 100 mM KCl; 2 mM MgCl 2 ; 0.1 mM CaCl 2 ; 50 mM sucrose; 5 mM EGTA; pH = 7.7) and added to 0.5 lg a-Myc antibodies coupled to Dynabeads â Protein G (Thermo Fisher). After 1 h incubation at 23°C, the beads were washed four times in Kinase Buffer (5 mM MOPS; 2.5 mM b-glycerophosphate; 5 mM MgCl 2 ; 1 mM EGTA; 0.4 mM EDTA; 0.05 mM DTT; 0.025% Tween-20; pH = 7.2). The beads were resuspended in 40 ll Kinase Buffer containing 2.5 mM ATP and 1,000 units recombinant PKA (Calbiochem #539481). The reaction was incubated for 30 min at 30°C. The beads were washed seven times in Kinase Buffer and three times in Phosphatase Buffer (50 mM HEPES; 10 mM CaCl 2 ; 5 mM MgCl 2 ; 1 mM DTT; 0.025% Tween-20; 8.8 mM ascorbate; pH = 7.5).
Cdc20: 50.6 ll CSF extract was supplemented with 2.6 ll Flag-Cdc20 IVT. The mixture was added to 3.3 lg a-Flag antibodies coupled to Dynabeads â Protein G (Thermo Fisher). The reaction was incubated for 60 min at 20°C. The beads were washed three times with Phosphatase Buffer supplemented with 5 mM b-glycerophosphate and 2 mM NaF and two times with Phosphatase Buffer.
For both assays, the beads were resuspended in 22 ll Phosphatase Buffer supplemented with hs_CaN (R&D Systems) and calmodulin (Sigma-Aldrich) as indicated. The reaction was incubated at 30°C, and samples were taken at the indicated time points.
Analysis of XErp1 and PP2A-B 0 56 interaction 80 ll CSF extract was supplemented with 1.9 lg Flag-B 0 56e mRNA and 4 ll Myc-XErp1 IVT. The whole reaction was added to 5 lg a-Flag antibodies coupled to Dynabeads â Protein G (Thermo Fisher). The reaction was incubated for 2 h at 23°C. 200 ll Wash Buffer (20 mM HEPES; 100 mM KCl; 5 mM MgCl 2 ; 0.025% Tween-20; 1× Protease Inhibitor Complete (Roche); pH = 7.5) was added, and the whole supernatant was removed. The beads were washed three times with Wash Buffer. The beads were treated with k-phosphatase.
Statistical analysis
Statistical analysis was carried out using Microsoft Excel. Values are given as mean AE SD. Statistical significance was probed using unpaired two-sided t-test (with unequal variance).
